You are here: Industry Insights > COVID-19

News List

Dexamethasone to be available on NHS as COVID-19 treatment europeanpharmaceuticalreview
June 23, 2020
The UK government has approved dexamethasone to be available on the NHS, following clinical trials proving its efficacy at reducing the risk of death for COVID-19 patients.
IPA launches a digital campaign to ensure uninterrupted medicines supply during COVID-19 pandemic expresspharma
June 23, 2020
The campaign, called Mission Medicine- Delivering Life, aims to bring to light the human stories of the contributions made by people engaged in the pharma sector amidst the COVID-19 pandemic and subsequent lockdown.
Antibody levels in recovered COVID-19 patients decline quickly: research expresspharma
June 23, 2020
The research highlights the risks of using COVID-19 ‘immunity passports’ and supports the prolonged use of public health interventions such as social distancing and isolating high-risk groups, researchers said.
Small market cap companies more dependent on COVID-19 pipeline drug: GlobalData expresspharma
June 23, 2020
The small-cap bio/pharma companies without a COVID-19 drug, on average, declined by 19.4 per cent.
Catalent Partners with ViralClear on Potential Treatment for COVID-19 contractpharma
June 23, 2020
Catalent will be developing two oral dosage forms of ViralClear’s broad-spectrum anti-viral agent merimepodib.
COVID-19 Pandemic Dramatically Increased Out-of-Hospital Cardiac Arrest Cases and Deaths in New York City prnewswire
June 22, 2020
The COVID-19 pandemic in New York City caused a surge in out-of-hospital cardiac arrests and deaths, according to a study co-authored by researchers at Albert Einstein College of Medicine, Montefiore Health System, and ...
Mayo finds convalescent plasma safe for diverse patients with COVID-19 worldpharmanews
June 22, 2020
Mayo Clinic researchers and collaborators have found investigational convalescent plasma to be safe following transfusion in a diverse group of 20,000 patients.
FDA Authorizes First Next Generation Sequence Test for Diagnosing COVID-19 americanpharmaceuticalreview
June 22, 2020
The U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) to Illumina, for the first COVID-19 diagnostic test utilizing next generation sequence technology.
Vivera Files First of Two US Made COVID-19 Antibody Tests americanpharmaceuticalreview
June 22, 2020
Vivera Pharmaceuticals has announced the launch of their point-of-care ready rapid serology tests.
J&J Accelerates COVID-19 Vaccine Candidate americanpharmaceuticalreview
June 22, 2020
Johnson & Johnson announced through Janssen Pharmaceutical, it has accelerated the initiation of the Phase 1/2a first-in-human clinical trial of its investigational SARS-CoV-2 vaccine, Ad26.COV2-S, recombinant.